The overall objective of the Feasibility of Retinoic Acid Treatment in Emphysema (FORTE) study is to conduct preliminary studies at 5 clinical centers preparatory to conducting a randomized, controlled, clinical trial on the efficacy of retinoic acid therapy in the management of emphysema. Objectives are to identify optimal patient populations, drugs and dosing schedules, and outcome measures for a large study, if indicated. This project serves as the Data Coordinating Center which will collect, verify, store, and analyze data from the Clinical Centers.
| Pragman, Alexa A; Kim, Hyeun Bum; Reilly, Cavan S et al. (2012) The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7:e47305 |
| D'Armiento, Jeanine M; Scharf, Steven M; Roth, Michael D et al. (2009) Eosinophil and T cell markers predict functional decline in COPD patients. Respir Res 10:113 |
| Muindi, Josephia R; Roth, Michael D; Wise, Robert A et al. (2008) Pharmacokinetics and metabolism of all-trans- and 13-cis-retinoic acid in pulmonary emphysema patients. J Clin Pharmacol 48:96-107 |
| Roth, Michael D; Connett, John E; D'Armiento, Jeanine M et al. (2006) Feasibility of retinoids for the treatment of emphysema study. Chest 130:1334-45 |
| Guo, Xu; Pan, Wei; Connett, John E et al. (2005) Small-sample performance of the robust score test and its modifications in generalized estimating equations. Stat Med 24:3479-95 |
